Judge Orders Discovery On Clinton Email And Benghazi

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
130
Judge Orders Discovery On Clinton Email And Benghazi Scandals:

Top Obama Officials Must Answer Questions Under Oath



The noose is tightening. You hear that, Hillary? There’s a storm coming for you and all the cronies who followed your orders to break laws and put our country’s national security in jeopardy, all because they thought you were going to be president and their lawbreaking wouldn’t matter, because you would have swept it all under the rug.

Today Judicial Watch announced that U. S. District Judge Royce C. Lamberth ruled that discovery will begin in Hillary Clinton’s email scandal.


Obama administration senior State Department officials, lawyers, and Clinton aides will now be deposed under oath. They have had over two years to come up with corroborating lies, but they can’t escape the truth. Hillary Clinton violated the Espionage Act, and many of her aides may have as well.


Senior Obama officials, including Susan Rice, Ben Rhodes, Jacob Sullivan, and FBI official E.W. Priestap, will now have to answer Judicial Watch’s written questions under oath.


The court rejected the DOJ and State Department’s objections to Judicial Watch’s court-ordered discovery plan.

First of all, why would the DOJ and State Department reject a discovery plan that is designed to get to the truth of serious crimes that were committed?
To cover up for people who still work in both the DOJ and State Department. It sounds like their loyalties are still with Obama and Hillary Clinton and not the country.

Further, why did the establishment media not make a big deal about deep state people inside DOJ and State fighting discovery steps to look into serious crimes committed? Because they’ve been in collusion with the Obama-Clinton people all along covering for them every time a story comes up about the lawlessness that went on under the Obama regime. Can you imagine the selective outrage if this were the Trump administration?

Incidentally, the court while ordering a discovery plan last month, ruled that the Clinton email system was “one of the gravest modern offenses to government transparency.” Apparently, the judge doesn’t want to wipe this case off with a cloth.

Here’s what the JW discovery is looking at for answers:

Whether Clinton intentionally attempted to evade the Freedom of Information Act (FOIA) by using a non-government email system;
whether the State Department’s efforts to settle this case beginning in late 2014 amounted to bad faith; and
whether the State Department adequately searched for records responsive to Judicial Watch’s FOIA request.

From Judicial Watch:

Judge Lamberth ordered written responses under oath to Judicial Watch’s questions from Obama administration senior officials Rice, Rhodes and Sullivan, and former FBI official Priestap. Rice and Rhodes will answer interrogatories under oath on the Benghazi scandal. Rejecting the State and Justice Department objections to discovery on the infamous Benghazi talking points, Judge Lamberth reiterated:

Yet Rice’s talking points and State’s understanding of the attack play an unavoidably central role in this case: information about the points’ development and content, as well as their discussion and dissemination before and after Rice’s appearances could reveal unsearched, relevant records; State’s role in the points’ content and development could shed light on Clinton’s motives for shielding her emails from FOIA requesters or on State’s reluctance to search her emails.

Millions of Americans will never forget the day fired and disgraced former FBI Director James Comey laid out a perfect case to the nation on television that even a first-year law student could have gotten a number of convictions on, only to let Hillary Clinton off the hook.
He gave us bogus reasons for his decision and even usurped powers of the Attorney General, the FBI, and the judiciary in the process. I would love to see James Comey deposed, even though he has enough legal problems of his own at the moment for all the criminal things he did like violating the same statute of the Espionage Act by which he let Hillary Clinton off the hook.

It will be interesting to see how the establishment news media will spin this.

https://davidharrisjr.com/politics/judge-orde...Ie8R8LXizQ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading